Study Finds This Surprising Workout Adds 10 Years To Your Life—And It's Not Walking Or Weights
The research involved 8,577 participants in Denmark, with an average age of 44, and the risk of all-cause and cardiovascular mortality was calculated based on the answers participants gave in a series of questionnaires around the frequency and duration of exercise they do, lifestyle factors like smoking, diet and alcohol consumption, and their education, income and medical history.
Those who did tennis were expected to live 9.7 years longer than if they didn't do any exercise; those who ran had a life expectancy gain of 3.2 years; and those who did gym training, like weights, only had a 1.5-year longer life expectancy.
If you're skeptical, another study published in the British Journal of Sports Medicine, reinforces the findings. This one tracked over 80,000 participants for nine years, comparing the impact of various sports on their overall health. Those who regularly played racket sports–including tennis, but also badminton, squash, racquetball, and table tennis–had a 47% lower chance of all-cause mortality than those who didn't exercise.
The study also evaluated the benefits of swimming, cycling, and aerobics: swimmers had a 28% lower risk, cyclists had a 15% lower risk, and those who did aerobics had a 27% lower risk.
Tennis (and racket sports) are clear winners, but why? For the authors of the Danish study, they believe it's largely down to the element of social interaction. It fosters camaraderie, emotional support, trust, and a sense of belonging–all of which have been proven to impact health just as much as how much movement you do or how nutritious your diet is.
Other experts put it down to the high-intensity interval training effect: tennis naturally involves short bursts of intense effort, like sprints and rapid direction changes, which improve cardiovascular fitness, insulin sensitivity, and vascular function–health markers closely tied to longevity.
So, if you're already feeling inspired by Wimbledon, consider this your sign to book a court stat.
Get the Workouts
Get the Challenge
Get the Workouts
Get the Challenge
Get the Workouts
Get the Workouts
Get the Challenge
Get the Workouts
Get the Workouts
Get the Workouts
Get the Workouts
Get the Workouts
Get the Workouts
Get the Challenge
Get the Workouts
Get the Workouts
You Might Also Like
Jennifer Garner Swears By This Retinol Eye Cream
These New Kicks Will Help You Smash Your Cross-Training Goals
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
an hour ago
- Forbes
Future Forecasting An S-Curve Pathway That Advances AI To Become AGI By 2040
Identifying the S-curve pathway from current AI to the attainment of AGI. In today's column, I am continuing my special series covering the anticipated pathways that will get us from conventional AI to the eagerly sought attainment of AGI (artificial general intelligence). Here, I undertake an analytically speculative deep dive into the detailed aspects of a distinctive S-curve route. I've previously outlined that there are seven major paths for advancing AI to reach AGI (see the link here) -- the S-curve avenue posits that we will have a period of AI advancement that hits a plateau, and then after residing in this stagnating plateau for a while, new advancements will ramp up again and bring us to AGI. Let's talk about it. This analysis of an innovative AI breakthrough is part of my ongoing Forbes column coverage on the latest in AI, including identifying and explaining various impactful AI complexities (see the link here). For those readers who have been following along on my special series about AGI pathways, please note that I provide similar background aspects at the start of this piece as I did previously, setting the stage for new readers. Heading Toward AGI And ASI First, some fundamentals are required to set the stage for this weighty discussion. There is a great deal of research going on to further advance AI. The general goal is to either reach artificial general intelligence (AGI) or maybe even the outstretched possibility of achieving artificial superintelligence (ASI). AGI is AI that is considered on par with human intellect and can seemingly match our intelligence. ASI is AI that has gone beyond human intellect and would be superior in many if not all feasible ways. The idea is that ASI would be able to run circles around humans by outthinking us at every turn. For more details on the nature of conventional AI versus AGI and ASI, see my analysis at the link here. We have not yet attained AGI. In fact, it is unknown as to whether we will reach AGI, or that maybe AGI will be achievable in decades or perhaps centuries from now. The AGI attainment dates that are floating around are wildly varying and wildly unsubstantiated by any credible evidence or ironclad logic. ASI is even more beyond the pale when it comes to where we are currently with conventional AI. AI Experts Consensus On AGI Date Right now, efforts to forecast when AGI is going to be attained consist principally of two paths. First, there are highly vocal AI luminaires making individualized brazen predictions. Their headiness makes outsized media headlines. Those prophecies seem to be coalescing toward the year 2030 as a targeted date for AGI. A somewhat quieter path is the advent of periodic surveys or polls of AI experts. This wisdom of the crowd approach is a form of scientific consensus. As I discuss at the link here, the latest polls seem to suggest that AI experts generally believe that we will reach AGI by the year 2040. Should you be swayed by the AI luminaries or more so by the AI experts and their scientific consensus? Historically, the use of scientific consensus as a method of understanding scientific postures has been relatively popular and construed as the standard way of doing things. If you rely on an individual scientist, they might have their own quirky view of the matter. The beauty of consensus is that a majority or more of those in a given realm are putting their collective weight behind whatever position is being espoused. The old adage is that two heads are better than one. In the case of scientific consensus, it might be dozens, hundreds, or thousands of heads that are better than one. For this discussion on the various pathways to AGI, I am going to proceed with the year 2040 as the consensus anticipated target date. Besides the scientific consensus of AI experts, another newer and more expansive approach to gauging when AGI will be achieved is known as AGI convergence-of-evidence or AGI consilience, which I discuss at the link here. Seven Major Pathways As mentioned, in a previous posting I identified seven major pathways that AI is going to advance to become AGI (see the link here). Here's my list of all seven major pathways getting us from contemporary AI to the treasured AGI: You can apply those seven possible pathways to whatever AGI timeline that you want to come up with. Futures Forecasting Let's undertake a handy divide-and-conquer approach to identify what must presumably happen to get from current AI to AGI. We are living in 2025 and somehow are supposed to arrive at AGI by the year 2040. That's essentially 15 years of elapsed time. The idea is to map out the next fifteen years and speculate what will happen with AI during that journey. This can be done in a forward-looking mode and also a backward-looking mode. The forward-looking entails thinking about the progress of AI on a year-by-year basis, starting now and culminating in arriving at AGI in 2040. The backward-looking mode involves starting with 2040 as the deadline for AGI and then working back from that achievement on a year-by-year basis to arrive at the year 2025 (matching AI presently). This combination of forward and backward envisioning is a typical hallmark of futurecasting. Is this kind of a forecast of the future ironclad? Nope. If anyone could precisely lay out the next fifteen years of what will happen in AI, they probably would be as clairvoyant as Warren Buffett when it comes to predicting the stock market. Such a person could easily be awarded a Nobel Prize and ought to be one of the richest people ever. All in all, this strawman that I show here is primarily meant to get the juices flowing on how we can be future forecasting the state of AI. It is a conjecture. It is speculative. But at least it has a reasonable basis and is not entirely arbitrary or totally artificial. I went ahead and used the fifteen years of reaching AGI in 2040 as an illustrative example. It could be that 2050 is the date for AGI instead, and thus this journey will play out over 25 years. The timeline and mapping would then have 25 years to deal with rather than fifteen. If 2030 is going to be the AGI arrival year, the pathway would need to be markedly compressed. AGI S-Curve Path From 2025 To 2040 The S-curve is distinctive since it consists of an S-shape such that the pathway initially has notable progress, hits an extended plateau and not much is advancing, and then proceeds to get underway again with a bit of a flourish on the tail-end. This is in stark contrast to a linear pathway. In a linear pathway, the progression of AI toward AGI is relatively equal each year and consists of a gradual incremental climb from conventional AI to AGI. I laid out the details of the linear path in a prior posting, see the link here. For ease of discussion about the S-curve pathway, let's assume that over the fifteen years, the first phase of the S-curve will be five years long, the plateau will be five years in length, and the tail-end will be five years too. This doesn't have to be the case and the length for each phase could differ. For example, maybe the upfront phase is three years, the plateau is eight years, and the final phase is four years. Using five years per phase is well illustrative and sufficient for this analysis. The S-curve phases will be conveniently depicted this way: There is an overlapping at the boundary years of 2030 and 2035. Also, for this depiction, I'll lump the individual years into the three noted phases. Here then is a strawman futures forecast roadmap from 2025 to 2040 of an S-curve pathway getting us to AGI: Years 2025-2030 (First phase of S-curve): Years 2030-2035 (Second phase of S-curve, the plateau): Years 2035-2040 (Third phase of S-curve, resumption): Contemplating The Timeline I'd ask you to contemplate the strawman S-curve timeline and consider where you will be and what you will be doing during each of those three phases and fifteen years. As per the famous words of Mark Twain: 'The future interests me -- I'm going to spend the rest of my life there.' You have an opportunity to actively participate in where AI is heading and help in shaping how AGI will be utilized. AGI, if attained, will change the world immensely and you can play an important part in how this happens.
Yahoo
an hour ago
- Yahoo
Boston Scientific's (BSX) FARAPULSE Approved by FDA for Expanded Labeling
Boston Scientific Corporation (NYSE:BSX) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 7, Boston Scientific Corporation (NYSE:BSX) announced that it has obtained approval to expand the instructions for use (IFU) labeling for the FARAPULSE Pulsed Field Ablation (PFA) System from the US Food and Drug Administration (FDA). The new labeling will allow the system to be used in the treatment of drug-refractory, symptomatic persistent atrial fibrillation (AF), a condition where the heart beats abnormally for a minimum of seven days. A surgeon examining a patient's brain in an operating room, paramedics nearby. Boston Scientific Corporation (NYSE:BSX) expects to receive approval in Europe, Japan, and China in the coming months. This will make the system available to more patients around the world in the near future. Boston Scientific Corporation (NYSE:BSX) is an American biotechnology and biomedical engineering firm that offers a portfolio of devices and therapies that help physicians diagnose and treat cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions. While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
'Demonised' drink actually has healthy benefits
A nutritional expert has praised a popular drink that is often 'demonised' by many for having negative impacts on heart rate and blood pressure. Tim Spector revealed how coffee can actually lower the likelihood of type 2 diabetes, heart disease, certain cancers and depression. That's despite a lot of critics saying that coffee can be detrimental to your heart rate and blood pressure in the short term. But the professor of genetic epidemiology at King's College London championed its benefits, reports GloucestershireLive. Professor Spector is also the co-founder of the health app Zoe. He spoke of the potential benefits whilst on a podcast with coffee expert James Hoffman. READ MORE: BBC Strictly Come Dancing star praised for 'real' Instagram post as fans share support Get breaking news on BirminghamLive WhatsApp, click the link to join The scientist explained that there are essential nutrients packed in coffee, which also has a surprising amount of five. And studies have also shown that it could reduce heart attack risks by 25%. And Prof Spector added that he is working on a scientific paper on coffee and the gut microbiome, and how interactions between the two can reduce our blood pressure and blood sugar. Watch the full discussion here. He said: 'What are the health benefits? One of the key things in coffee. It's a complex area, but I think we're suddenly putting it together from a drink that was demonised as being very harmful to us to something that actually could be beneficial. Coffee is this fermented plant that has microbes acting on. 'It has hundreds, not thousands, of chemicals produced from it. There's range of polyphenols that are enhanced by the microbes as they ferment it. And those have direct effects on our body, and some of them can reduce blood sugar and reduce stress and actually reduce blood pressure. And the studies have now clearly shown that you get nearly as much benefit on the heart with decaffeinated coffee.' Speaking previously in a health Q&A on his Instagram page, Prof Spector answered a number of questions about healthy eating and drinking - including how much coffee is healthy, eating breads and how to find and eat cheap vegetables and fruits. His answer on coffee is perhaps the most surprising - because he suggests people should have lots of it. He said: 'Coffee is a health food, and we should all be drinking at least three cups a day, according to the latest science. And it doesn't matter if you don't want caffeine, just have decaf. It's probably just as healthy. 'In fact studies have shown that moderate coffee intake—about 2–5 cups a day—is linked to a lower likelihood of type 2 diabetes, heart disease, liver and endometrial cancers, Parkinson's disease, and depression. It's even possible that people who drink coffee can reduce their risk of early death.'
